Taiwan has signed a second contract with American drugmaker Pfizer to procure 350,000 courses of their COVID-19 treatment medicine Paxlovid, which will arrive by the end of June, Minister of Health and Welfare Chen Shih-chung (陳時中) said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
KMT chair-elect expresses opposition to 5% GDP defense budget
10/29/2025 05:04 PM - Science & Tech
Wistron to inaugurate AI supercomputing facilities in Texas in H1 of 2026
10/29/2025 04:46 PM - Business
Taiwan shares end at almost 28,300 points amid Nvidia's AI optimism
10/29/2025 04:35 PM - Business
U.S. dollar closes higher on Taipei forex market
10/29/2025 04:17 PM - Society
Comet Lemmon to reach peak brightness Thursday evening
10/29/2025 03:16 PM